[Ip-health] Alan Story: A patented Covid-19 vaccine could price out millions | Green World

Mohga Kamal-Yanni MohgaKY at access2healthcare.net
Thu May 7 08:44:21 PDT 2020


Hi
This is a very very worrying comment given his position (but hardly surprising from him). Business was not as usual when the US was on the verge of issuing CL on cipro after 9/11

Even an X Novartis talked about this as not business as usual and said public health must be the driver not commercial interest. 

This is unprecedented pandemic requites unprecedented actions including IP pool. 


Best Wishes  مع أطيب التمنيات 
Mohga

Dr. Mohga Kamal-Yanni MPhil. MBE
Global Health and Access to Medicines Consultant
Tel: +44 (0) 777 62 55 884
E mail: Mohga at access2healthcare.net

-----Original Message-----
From: Ip-health <ip-health-bounces at lists.keionline.org> On Behalf Of James Love
Sent: 07 May 2020 15:58
To: Ip-health <ip-health at lists.keionline.org>
Subject: [Ip-health] Alan Story: A patented Covid-19 vaccine could price out millions | Green World

Alan story has a long piece on the patents issues related to vaccines.  One thing that sticks out is a telling quote from Dick Wilder at CEPI on the issue of open licensing.  This is pretty significant, given the amount of money from government and private donors to CEPI for vaccine development.

Jamie


https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgreenworld.org.uk%2Farticle%2Fpatented-covid-19-vaccine-could-price-out-millions&data=02%7C01%7C%7C2d20eb624adc4f84236108d7f2974647%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637244603836669268&sdata=9u1iWtSy2f4SfbIjsMAaFdSfCLDEfOHydifN0UgxlPE%3D&reserved=0


The Costa Rica proposal is “not effective and not necessary”, Richard Wilder, general legal counsel of the Coalition for Epidemic Preparedness Innovations (CEPI) told Green World last week in an exclusive interview.

Wilder, who is also CEPI’s director of business development, said pharmaceutical companies, biotech firms and academic labs will refuse to share their vaccine technologies and scientific processes and there is “simply no time now” to do anything different than usual.


This then becomes a key question of the hour: is the need for a Covid-19 vaccine, its manufacture and its distribution now so great that “business as usual”, as Ellen ‘t Hoen puts it, is a non-starter? And will governments require patent holders to share?




--
James Love.  Knowledge Ecology International U.S. Mobile +1.202.361.3040 U.S. office phone +1.202.332.2670
https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.keionline.org%2F&data=02%7C01%7C%7C2d20eb624adc4f84236108d7f2974647%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637244603836669268&sdata=3A4oh0gL4XzFfF40U8Qwf5NC67KSctZBfvpFv6hCsLw%3D&reserved=0 <https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.keionline.org%2Fdonate.html&data=02%7C01%7C%7C2d20eb624adc4f84236108d7f2974647%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637244603836669268&sdata=nHBZyh0CrQntNL9DYn0geaXND2%2BBMgUO8qldrwwNPVs%3D&reserved=0>
twitter.com/jamie_love
_______________________________________________
Ip-health mailing list
Ip-health at lists.keionline.org
https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Flists.keionline.org%2Fmailman%2Flistinfo%2Fip-health_lists.keionline.org&data=02%7C01%7C%7C2d20eb624adc4f84236108d7f2974647%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637244603836669268&sdata=ANQOksmqCQT7F5bzVmRuJxAqIledxxCE1S1gTWGlBl8%3D&reserved=0


More information about the Ip-health mailing list